[HTML][HTML] Diabetes mellitus, insulin resistance and hepatitis C virus infection: A contemporary review

AC Desbois, P Cacoub - World journal of gastroenterology, 2017 - ncbi.nlm.nih.gov
AIM To summarise the literature data on hepatitis C virus (HCV)-infected patients concerning
the prevalence of glucose abnormalities and associated risk. METHODS We conducted a …

[HTML][HTML] Hepatitis C virus, insulin resistance, and steatosis

D Kralj, LV Jukić, S Stojsavljević… - Journal of clinical and …, 2016 - ncbi.nlm.nih.gov
Hepatitis C virus (HCV) is one of the main causes of liver disease worldwide. Liver steatosis
is a common finding in many hepatic and extrahepatic disorders, the most common being …

Impact of direct acting antiviral (DAA) treatment on glucose metabolism and reduction of pre-diabetes in patients with chronic hepatitis C.

P Weidner, D Boettche, T Zimmerer… - … of Gastrointestinal & …, 2018 - search.ebscohost.com
Abstract Background & Aim: With the development of direct acting antiviral agents
(DAA) chronic hepatitis C virus (HCV) infection has become curable in most patients. Since …

Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies

MH Ismail, M Pinzani - Hepatic medicine: evidence and research, 2011 - Taylor & Francis
Chronic liver injuries of different etiologies eventually lead to fibrosis, a scarring process
associated with increased and altered deposition of extracellular matrix in the liver …

Serum Mac-2 binding protein glycosylation isomer concentrations are associated with incidence of type 2 diabetes

M Higashioka, Y Hirakawa, J Hata… - The Journal of …, 2023 - academic.oup.com
Abstract Context Serum Mac-2 binding protein glycosylation isomer (M2BPGi)
concentrations are known to be an indicator of chronic liver injury and fibrosis. Objective …

Effects of HCV Clearance with Direct-Acting Antivirals (DAAs) on Liver Stiffness, Liver Fibrosis Stage and Metabolic/Cellular Parameters

J Ferreira, M Bicho, F Serejo - Viruses, 2024 - mdpi.com
Introduction: Chronic hepatitis C (CHC) is a clinical and pathological syndrome with various
causes and is characterized by varying degrees of hepatocellular necrosis and …

Insulin resistance and prediabetes in hepatitis C virus patients

DE Desouky, Z Kasemy, AE Abdel-Hamid… - The American Journal of …, 2015 - Elsevier
Background Egypt has the highest prevalence of hepatitis C virus (HCV) infection in the
world and is facing an epidemic of type 2 diabetes mellitus. The objective of this study was to …

[PDF][PDF] The association between insulin resistance and hepatic fibrosis in patients with chronic hepatitis C: an observational, multicenter study in Turkey

A Dokmeci, Y Üstündağ, S Hulagu… - Turkish Journal of …, 2014 - avesis.gazi.edu.tr
The association between insulin resistance and hepatic fibrosis in patients with chronic
hepatitis C: An observational, multicen Page 1 Turk J Gastroenterol 2014; 25: 546-52 The …

Advanced glycation end products as a predictor of diabetes mellitus in chronic hepatitis C-related cirrhosis

A Abdel-Razik, N Mousa, S Zakaria… - Frontiers in …, 2020 - frontiersin.org
Background and Aims: Advanced glycation end products (AGEs) were found to be involved
in the pathogenesis of various disorders. Chronic hepatitis C virus infection is the major …

Correlation of Serum Hepatitis C Viral Load and Immunobiochemical biomarkers in Combined Therapy Treated Patients

FA Ibrahim, MG Soliman… - International Journal of …, 2023 - ijtar.journals.ekb.eg
Hepatitis C virus (HCV) infection is a major global disease that frequently causes chronicity
and has the potential to cause liver failure and it is widespread in Egypt. Direct acting …